Related Experiment Videos
Late relapse from complete remission in nodular and diffuse histiocytic lymphoma
Cancer
|October 15, 1983
Summary
Late relapses occurred in patients with unfavorable prognosis lymphomas, even years after remission. These late events may represent tumor regrowth or second malignancies, highlighting the need for long-term patient monitoring.
Area of Science:
- Oncology
- Hematology
- Radiation Oncology
Background:
- This study examines late disease relapse in patients diagnosed with unfavorable prognosis lymphomas.
- Patients received treatment primarily consisting of radiation therapy.
Observation:
- Twelve patients with diffuse histiocytic lymphoma (n=11) and nodular histiocytic lymphoma (n=1) achieved complete remission.
- Disease relapse occurred significantly late, ranging from 2.8 to 26 years post-remission (median 6.25 years).
Findings:
- Late relapses in lymphomas suggest potential regrowth of dormant tumor cells.
- Alternatively, these late events could indicate the development of secondary malignancies in susceptible individuals.
Implications:
- Long-term follow-up is crucial for patients with unfavorable prognosis lymphomas to detect late relapses.
- Understanding the mechanisms behind late relapse is important for refining treatment strategies and improving patient outcomes.